Literature DB >> 7594446

Risks and benefits of treating mild hypertension: a misleading meta-analysis?

M Egger1, G D Smith.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7594446     DOI： 10.1097/00004872-199507000-00014

Source DB:  PubMed          Journal:  J Hypertens        ISSN： 0263-6352            Impact factor:   4.844


× No keyword cloud information.
  7 in total

Review 1.  The relation between treatment benefit and underlying risk in meta-analysis.

Authors:  S J Sharp; S G Thompson; D G Altman
Journal:  BMJ       Date:  1996-09-21

Review 2.  Multiple risk factor interventions for primary prevention of coronary heart disease.

Authors:  S Ebrahim; A Beswick; M Burke; G Davey Smith
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

3.  Statins for primary prevention: at what coronary risk is safety assured?

Authors:  P R Jackson; E J Wallis; I U Haq; L E Ramsay
Journal:  Br J Clin Pharmacol       Date:  2001-10       Impact factor: 4.335

4.  What constitutes controlled hypertension? Patient based comparison of hypertension guidelines.

Authors:  T P Fahey; T J Peters
Journal:  BMJ       Date:  1996-07-13

5.  Applying the results of clinical trials to patients to general practice: perceived problems, strengths, assumptions, and challenges for the future.

Authors:  T Fahey
Journal:  Br J Gen Pract       Date:  1998-04       Impact factor: 5.386

Review 6.  Endotoxemia and mortality prediction in ICU and other settings: underlying risk and co-detection of gram negative bacteremia are confounders.

Authors:  James C Hurley; Bertrand Guidet; Georges Offenstadt; Eric Maury
Journal:  Crit Care       Date:  2012-08-07       Impact factor: 9.097

Review 7.  Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries.

Authors:  Olalekan A Uthman; Louise Hartley; Karen Rees; Fiona Taylor; Shah Ebrahim; Aileen Clarke
Journal:  Cochrane Database Syst Rev       Date:  2015-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.